Advertisement

News & Insights

Latest Biobanking Industry News and Insights

FDA Grants Nohla Therapeutics’ Cell Therapy Dilanubicel Orphan Drug Designation for HSCT

  Nohla Therapeutics, headquartered in Seattle, is a leading developer of “off-the shelf” cell therapies for patients with cancer and other diseases. Nohla’s proprietary notch...

Biobanking Consent: Informing Human Subjects of the Possibilities

As researchers, we are familiar with why we have the need for biobanking regulations due to the story of Henrietta Lacks. HeLa cells survived...

Cell Therapy – New Method To Reprogram T-cells Without Viral Vectors Developed At UCSF

  A new method has been developed, primarily by University of California San Francisco (UCSF) researcher Theo Roth of Alex Marson’s laboratory, to introduce gene...

ARMADA, The Antibiotic Resistance Monitoring, Analysis And Diagnostics Alliance Biobank

ARMADA, is the Antibiotic Resistance Monitoring, Analysis and Diagnostics Alliance. It will be a publicly supported Global Biobank that will, for the first time,...

BC Platforms And Tieto Partner To Advance Precision Medicine For Nordic Healthcare Providers

BC Platforms, founded in 1997 from an MIT Whitehead project spinoff, is in the business of powerful genomic data management and analysis solutions. The...

Biotime Has Licensed One Of Its Pluripotent Cell Lines To GoLiver

BioTime Inc. is a clinical-stage biotechnology company, headquartered in the San Francisco Bay Area, focused on degenerative diseases. Its clinical programs are based on...

Indivumed And Singapore’s A*STAR Sign Agreement For Multiomics Analysis Of Biobank

Indivumed GmbH, an International Organization for Standardization (ISO) certified global oncology research company based in Hamburg, Germany, has established the world's leading Cancer Database...

FDA Grants RMAT Designation To Cellerant’s “Off-The-Shelf” Romyelocel-L Cell Therapy

Cellerant Therapeutics Inc., is a clinical-stage company developing innovative cell and antibody-based immunotherapies for hematologic malignancies and other blood-related disorders. Cellerant’s romyelocel-L (human myeloid...

The Dalglish Family 22q Clinic And Biobank

The Dalglish Family 22q Clinic is the world's first multidisciplinary clinic devoted to adults with 22q11.2 deletion syndrome (22q11.2DS) and their families, located at...

Bruker B.I.BioBankTool™ For Biobank Standardization And Quality Control

Bruker Corporation is a manufacturer of analytical and medical instruments, for use in applied and pharma applications, in microscopy and nanoanalysis, and in industrial...

IPS HEART Aims To Use Induced Pluripotent Stem Cells To Treat Heart Attack

IPS HEART is a privately-held biopharmaceutical company, founded in 2014, dedicated to addressing heart attack, heart failure and Duchenne cardiomyopathy via next generation cellular...

In-Home Clinical Services Enhanced By LabConnect And Symphony Clinical Research Partnership

LabConnect, LLC, was founded in 2002, providing a global central laboratory, biorepository and client-inspired support services which include routine specialized laboratory testing, kit building,...

Biobanking Market Report


Most Popular

Stay Connected

446FollowersFollow